论文部分内容阅读
目的研究3种措施治疗宫颈柱状上皮异位患者的临床效果及安全性。方法选择2012年11月-2014年3月收治的156例慢性宫颈炎患者,按照患者入院顺序将所有患者分为保妇康栓组(n=52)、干扰素组(n=52)和联合用药组(n=52)。保妇康栓组患者采取保妇康栓治疗,干扰素组患者肌内注射干扰素注射液,联合用药组患者采取保妇康栓与干扰素同时进行。对比分析3种措施治疗的情况。通过治疗后访问的形式观察3组患者的症状改善状况。观察3种不同程度宫颈柱状上皮异位程度采取3种不同治疗措施所带来的不同疗效。结果干扰素组所用的治疗时间最长,阴道排液时间最长的为保妇康栓组,与其他两组进行比较,均有统计学意义(P<0.05)。宫颈柱状上皮异位患者为轻度时,3种不同的治疗措施,其疗效没有显著性差异(P>0.05),而宫颈柱状上皮异位患者为中重度时,保妇康栓组与联合用药组的疗效显著优于干扰素组,差异具有统计学意义(P<0.05)。在阴道分泌物改善方面,联合用药组的改善效果最佳,其改善率为92.31%,联合用药组的腰部症状改善率为94.23%,与其他两组进行比较,其改善效果较为明显,差异具有统计学意义(P<0.05)。结论 3种不同治疗措施均有各自的优缺点,因此,针对不同宫颈柱状上皮异位程度患者应选择不同的治疗措施,具有不同的临床疗效和安全性。
Objective To study the clinical effects and safety of three kinds of measures in patients with cervical columnar epithelial ectopic patients. Methods A total of 156 patients with chronic cervicitis admitted from November 2012 to March 2014 were enrolled in this study. All patients were divided into two groups according to admission sequence: nongkonang suppository group (n = 52), interferon group (n = 52) The medication group (n = 52). Baofukang suppository group patients taking Baofukang suppository, interferon group intramuscular injection of interferon injection, the combination group of patients taking Baofukang suppository with interferon at the same time. Comparative analysis of three kinds of measures of treatment. Three groups of patients were observed for symptom improvement by post-treatment visit. To observe the three different degrees of cervical columnar epithelial heterotopic degree to take three different treatment measures brought about by different curative effect. Results Interferon group used the longest treatment time, vaginal discharge the longest time for the Baofukang suppository, compared with the other two groups, were statistically significant (P <0.05). When the patients with cervical columnar epithelial ectopic were mild, there were no significant differences in the curative effect between the three different treatment measures (P> 0.05) The efficacy of the group was significantly better than interferon group, the difference was statistically significant (P <0.05). In the improvement of vaginal discharge, the combination group improved the best, the improvement rate was 92.31%, the combination group of the waist symptom improvement rate was 94.23%, compared with the other two groups, the improvement is more obvious, the difference has Statistical significance (P <0.05). Conclusions The three different treatments have their own advantages and disadvantages. Therefore, different treatment measures should be taken for patients with different degrees of cervical columnar epithelial ectopic disease, with different clinical efficacy and safety.